AstraZeneca’s Evusheld Wins EU Marketing Nod For Preventing COVID-19
If Approved Evusheld Will Become The EU’s Eighth COVID-19 Treatment
The European Commission is expected to make a “rapid decision” on the European Medicines Agency’s recommendation today that Evusheld should be approved.
